These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12786612)

  • 21. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.
    Katz PO; Anderson C; Khoury R; Castell DO
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1231-4. PubMed ID: 9882031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.
    Frazzoni M; De Micheli E; Zentilin P; Savarino V
    Aliment Pharmacol Ther; 2004 Jul; 20(1):81-8. PubMed ID: 15225174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent views on the pathogenesis of gastro-oesophageal reflux disease.
    Dent J
    Baillieres Clin Gastroenterol; 1987 Oct; 1(4):727-45. PubMed ID: 3329541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of gastro-oesophageal reflux disease and novel options for its therapy.
    Dent J
    Neurogastroenterol Motil; 2008 May; 20 Suppl 1():91-102. PubMed ID: 18402646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients.
    Emerenziani S; Habib FI; Ribolsi M; Caviglia R; Guarino MP; Petitti T; Cicala M
    Aliment Pharmacol Ther; 2006 Mar; 23(6):751-7. PubMed ID: 16556177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nonerosive reflux disease-gastroesophageal reflux disease controversy.
    Winter JW; Heading RC
    Curr Opin Gastroenterol; 2008 Jul; 24(4):509-15. PubMed ID: 18622168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified inspiratory muscle training (m-IMT) as promising treatment for gastro-oesophageal reflux disease (GERD).
    Moffa A; Oliveto G; Matteo FD; Baptista P; Cárdenas A; Cassano M; Casale M
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(2):65-69. PubMed ID: 31103135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.
    Savarino E; Gemignani L; Pohl D; Zentilin P; Dulbecco P; Assandri L; Marabotto E; Bonfanti D; Inferrera S; Fazio V; Malesci A; Tutuian R; Savarino V
    Aliment Pharmacol Ther; 2011 Aug; 34(4):476-86. PubMed ID: 21671968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophagogastric junction contractile integral and morphology: Two high-resolution manometry metrics of the anti-reflux barrier.
    Ham H; Cho YK; Lee HH; Yoon SB; Lim CH; Kim JS; Park JM; Choi MG
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1443-1449. PubMed ID: 28061013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-reflux barrier and mechanisms of gastro-oesophageal reflux.
    Holloway RH
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct; 14(5):681-99. PubMed ID: 11003803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations.
    Barak N; Ehrenpreis ED; Harrison JR; Sitrin MD
    Obes Rev; 2002 Feb; 3(1):9-15. PubMed ID: 12119661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-oesophageal reflux disease.
    Broeders JA; Draaisma WA; Bredenoord AJ; Smout AJ; Broeders IA; Gooszen HG
    Br J Surg; 2010 Jun; 97(6):845-52. PubMed ID: 20473997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations.
    van Herwaarden MA; Samsom M; Smout AJ
    Gastroenterology; 2000 Dec; 119(6):1439-46. PubMed ID: 11113064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease.
    Kahrilas PJ; Quigley EM; Castell DO; Spechler SJ
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1503-9. PubMed ID: 11069322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology, diagnosis and treatment of non-erosive reflux disease (NERD).
    Papa A; Urgesi R; Grillo A; Danese S; Guglielmo S; Roberto I; Fedeli G; Gasbarrini A; Gasbarrini G
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):215-26. PubMed ID: 15729197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ethiopathogenesis of gastroesophageal reflux disease].
    Lukás K; Marecek P
    Cas Lek Cesk; 2000 Aug; 139(15):455-9. PubMed ID: 22666924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: indications for anti-reflux surgery in gastro-oesophageal reflux disease.
    Mattioli S; Lugaresi ML; Pierluigi M; Di Simone MP; D'Ovidio F
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():60-7. PubMed ID: 12786615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of gastroesophageal reflux disease correlated with a short dinner-to-bedtime interval.
    Yang JH; Kang HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    J Gastroenterol Hepatol; 2014 Apr; 29(4):730-5. PubMed ID: 24224689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury.
    Patti MG; Goldberg HI; Arcerito M; Bortolasi L; Tong J; Way LW
    Am J Surg; 1996 Jan; 171(1):182-6. PubMed ID: 8554137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.